Atlas Trials

Restem, LLC.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Restem, LLC.

RecordFirmDate
Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) (NCT07160205)Restem, LLC.2026-01-06
Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT07086521)Restem, LLC.2025-12-01
Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS (NCT04494386)Restem, LLC.2020-12-23

Track Restem, LLC. automatically

Every clearance here is in the API, with alerts when new ones post.